Severe mania complicating treatment of narcolepsy with cataplexy

Journal of Clinical Sleep Medicine

Volumn 7, Issue 2, 2011, Pages 214-216

  Crosby, Mark I ^a,b   Bradshaw, David A ^a   McLay, Robert N ^a  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b Naval Aerospace Medicine Institute   (United States)

Author keywords

Antidepressant; Bipolar disorder; Mania; Narcolepsy; Psychostimulant

Indexed keywords

FLUOXETINE; LITHIUM; MODAFINIL; VENLAFAXINE;

ADULT; ARTICLE; BIPOLAR DISORDER; CASE REPORT; CATALEPSY; CATAPLEXY; COMPULSION; DAYTIME SOMNOLENCE; DISEASE SEVERITY; HUMAN; HYPERACTIVITY; LOGORRHEA; MALE; MANIA; MOOD CHANGE; MUSCLE WEAKNESS; NARCOLEPSY; PARALYSIS; POLYSOMNOGRAPHY; UNPLEASANT DREAM;

EID: 79957985419     PISSN: 15509389     EISSN: 15509397     Source Type: Journal    
DOI: 10.5664/jcsm.28112     Document Type: Article

References (16)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association, 2000.
2. Arnsten AFT, Manji HK. Mania: a rational neurobiology. Future Neurol 2008;3:125-31. (Pubitemid 351385958)
3. Szabo S, Machado-Vieira R, Yuan P, et al. Glutamate receptors as targets of protein kinase C in the pathophysiology and treatment of animal models of mania. Neuropharmacology 2009;56:47-55.
4. Carlson PJ, Merlock MC, Suppes T. Adjunctive stimulant use in patients with bipolar disorder: treatment of residual depression and sedation. Bipolar Disord 2004;6:416-20.
5. Hegerl U, Hummerich H, Engmann B, Hensch T. Mania and attention-deficit/hyperactivity disorder: common symptomatology, common pathophysiology and common treatment? Curr Opin Psychiatry 2010;23:1-7.
6. Wingo AP, Ghaemi SN. Frequency of stimulant treatment and of stimulant associated mania/hypopmania in bipolar disorder patients. Psychol Bull 2008;41:37-47.
7. Morgenthaler TI, Kapur VK, Brown TM, et al; Standards of Practice Committee of the AASM. Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin. Sleep 2007;30:1705-11. (Pubitemid 350234749)
8. Frye MA, Grunze H, Suppes T, et al. A placebo-controlled evaluation of adjunctive modafanil in the treatment of bipolar depression. Am J Psychiatry 2007;164:1242-9. (Pubitemid 47292414)
9. Ginsberg DL. Modafinil-associated mania. Prim Psychiatry 2007;14:23-4. (Pubitemid 46134862)
10. Vorspan F, Warot D, Consoli A, Cohen D, Mazet P. Mania in a boy treated with modafinil for narcolepsy. Am J Psychiatry 2005;162:813-4. (Pubitemid 40489158)
11. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder. Am J Psychiatry 2002;159(Suppl. 4):1-50.
12. Post RM, Altshuler LL, Leverich GS, et al. Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. Br J Psychiatry 2006;189:124-31. (Pubitemid 44231270)
13. Vieta E, Martinez-Aran A, Goikolea JM, et al. A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers. J Clin Psychiatry 2002;63:508-12. (Pubitemid 34680359)
14. Gao K, Kemp DE, Ganocy SJ, et al. Treatment-emergent mania/hypomania during antidepressant monotherapy in patients with rapid cycling bipolar disorder. Bipolar Disord 2008;10:907-15.
15. Trzepacz PT. Concurrent narcolepsy and bipolar affective disorder. Psychosomatics 1987;28:219-21. (Pubitemid 17059278)
16. Fortuyn HA, Lappenschaar MA, Furer JW, et al. Anxiety and mood disorders in narcolepsy: a case-control study. Gen Hosp Psychiatry 2010;32:49-56.